On Sunday, September 24th, Bone Thugs-N-Harmony’s Krayzie Bone, whose real name is Anthony Henderson, was hospitalized and battling a “life-threatening” condition. According to All Hip Hop, the ...

With the popularity of the ECG certification exam, we have recently been seeing more niche questions in ECG books and problem ...

Sarcoidosis, which is also known as sarcoid or Besnier-Boeck disease, is a health condition involving the formation of small nodules known as granulomas at various sites of the body. Sarcoidosis is ...

A research team led by Georg Stary (Medical University of Vienna and CeMM) has identified a new approach to treating the inflammatory disease sarcoidosis. In a clinical study, the inhibition of a ...

A rare case of vulvar sarcoidosis highlights the value of biopsy when presumed lichen sclerosus is persistent, atypical, or ...

See References Table 1 in the Supplementary Appendix, available with the full text of this article at NEJM.org, for additional references pertaining to this table. An adverse prognosis indicates a ...

Global Phase 3 study will evaluate efzofitimod in patients with pulmonary sarcoidosis with restrictive lung disease utilizing FVC as primary ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Michelle M.

$500 HealthCare.gov refunds started arriving Sept. 30 with a Trump letter. Here's who qualifies, how payments arrive, and how to avoid copycat scams. Sudden Unexpected Infant Deaths Now Account for ...

aTyr Pharma Inc. ATYR secured a formal agreement with the U.S. Food and Drug Administration (FDA) regarding the Phase 3 study protocol for its lead therapeutic candidate, efzofitimod. Following this ...

Add Yahoo as a preferred source to see more of our stories on Google. Erica Courtenay-Mann avoided talking about her sarcoidosis — an inflammatory disease that impacts one or more organs throughout ...

Tyr Pharma plans to begin study-related activities in the fourth quarter of 2026 after reaching FDA alignment on a global Phase 3 efzofitimod trial, although further development will require ...